Michael Scolaro

Michael Scolaro

Sep 01, 2017

Group 6 Copy 124
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

    A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

    S-glutathionylation reactions in mitochondrial function and disease

    This project was an invited review that is currently under minor revision at Frontiers Cellular and Developmental...

    Manuka Honey: A New Tool in the Battle Against Antibiotic Resistance?

    Since settlers brought honeybees to New Zealand, inhabitants have utilized honey produced from the native...

    Backer Badge Funded